Demonstrates effective nitric oxide delivery in neurons, indicating a breakthrough in neuromodulation techniques.
Chemical neuromodulation offers a physiologically relevant approach to manipulate neural functions, yet current methods suffer from poor spatiotemporal precision, cargo instability, or requirements for genetic modification. Here, we report a near-infrared (NIR) light-controlled platform for on-demand nitric oxide (NO) delivery to neurons, using upconversion nanoparticles (UCNPs) coated with metal–organic framework shells covalently loaded with photolabile NO donors (UCNP@MOF-NO). The core–shell architecture exploits NIR-to-UV upconversion to photolytically release NO with spatiotemporal precision in deep brain regions, thereby modulating neuronal activity through endogenous signaling pathways. Covalent conjugation prevents small-molecule leakage, ensuring stability for over 1 week. Quantitative single-cell amperometric measurements reveal stimulus-evoked exocytosis in PC12 cells, while in vivo electrophysiological recordings demonstrate a ∼70% increase in spike firing frequency upon NIR irradiation. This work demonstrates NO-mediated neuromodulation at the single-cell level via endogenous signaling pathways, addresses fundamental challenges in modulating neurochemical signaling, and provides an alternative strategy for chemical neuromodulation.
No takes yet. Share an insight, caveat, or question.
Lai et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: